UTHR - United Therapeutics Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,725,3001,598,8001,465,800
Cost of Revenue105,70072,70069,000
Gross Profit1,619,6001,526,1001,396,800
Operating Expenses
Research Development264,600147,600245,100
Selling General and Administrative540,100316,800452,700
Non Recurring---
Total Operating Expenses---
Operating Income or Loss814,9001,061,700699,000
Income from Continuing Operations
Total Other Income/Expenses Net-36,4002,400350,100
Earnings Before Interest and Taxes778,5001,064,1001,049,100
Interest Expense9,0003,9004,700
Income Before Tax769,5001,060,2001,044,400
Income Tax Expense351,600346,500392,800
Minority Interest---
Net Income From Continuing Ops417,900713,700651,600
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income417,900713,700651,600
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares417,900713,700651,600